白色念珠菌
白色体
微生物学
生物
四氯化碳
病菌
真菌病原
免疫
系统性念珠菌病
体内
巨噬细胞
免疫学
炎症
免疫系统
趋化因子
体外
生物技术
生物化学
作者
Wang Tan,Jiayu Liu,Renlin Yu,Ping Zhao,Yuhan Liu,Qian Lu,Ke Wang,Hao Ding,Yi Liu,Xiaofei Lai,Ju Cao
出处
期刊:PLOS Pathogens
[Public Library of Science]
日期:2024-11-25
卷期号:20 (11): e1012747-e1012747
标识
DOI:10.1371/journal.ppat.1012747
摘要
Candida albicans is the most common aetiologic pathogen of fungal infections associated with high mortality in immunocompromised patients. There is an urgent need to develop new antifungal therapies owing to the poor efficacy and resistance of current antifungals. Here, we report that Trim72 positively regulates antifungal immunity during lethal fungal infection. Trim72 levels are significantly increased after Candida albicans infection. In vivo, Trim72 knockout significantly increases mortality, organ fungal burden and kidney damage in mice after lethal Candida albicans infection. Whereas recombinant Trim72 protein treatment protects mice against invasive candidiasis. Mechanistically, Trim72 facilitates macrophage infiltration and CCL2 production, which mediates Trim72-elicited protection against lethal Candida albicans infection. Furthermore, Trim72 may enhance macrophage migration and CCL2 production via NF-κB and ERK1/2 signaling. Inhibition of NF-κB and ERK1/2 signaling abrogates Trim72-mediated protection against lethal Candida albicans infection. Therefore, these data imply that Trim72 may be developed as a host-directed therapy for treating severe systemic candidiasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI